Position in SVTR
Snapshot 2026-10-25- Startup SignalsRankedof 2,341new
- Life SciencesRankedof 248
About
Channel Robotics, founded in 2023 in Del Mar, California, develops handheld robotic systems that add dexterity to flexible endoscopes, allowing surgeons to perform advanced minimally invasive procedures without large robotic platforms.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Founders / team· 2
Funding history
- 2026-06-18Seed+$3M
Investors · Defined VC, Old Line Capital Partners, True VenturesSource · prnewswire.com ↗
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Channel Robotics
Handheld robotic system adding dexterity to flexible endoscopes so physicians can perform advanced minimally invasive surgery without large robots
Seed · $5M · 2026-06
$5M
United States
BusinessLatest roundTotal raisedDate- Valius Sciences
Precision oncology diagnostics: integrated molecular profiling of tumors across DNA/RNA/protein layers, assessing actionable targets across tumor types, target heterogeneity and resistance mechanisms, benchmarked against large tumor datasets, delivered to physicians and patients as interactive software + shareable data (not static PDF reports)
Seed · $14M · 2026-04
$14M - Dopl Technologies
Hardware-agnostic teleoperated robotic ultrasound system
Seed · $8M · 2026-07
$8M - Lila Sciences
Uses AI to analyze data, design experiments and direct robotic systems to carry out experiments in the life sciences, chemistry and materials science
Series A · $550M · 2025-10
$550M
China
BusinessLatest roundTotal raisedDateEurope
BusinessLatest roundTotal raisedDate- Surgar
Augmented reality software to support surgeons during minimally invasive surgery
Undisclosed · $12M · 2024-09
$12M - Nami Surgical
Miniature ultrasonic medical devices for surgery; high-performance small ultrasonic scalpels designed to overcome obstacles in robot-assisted surgery
Undisclosed · $4M · 2024-05
$4M - Soundsafe Care
Robotic focused ultrasound devices for noninvasive tumor ablation, launching first with veterinary certification, then expanding to human tumor treatment.
$2M
$2M
Other / unspecified
BusinessLatest roundTotal raisedDate- Scopia Surgical
AI surgical navigation software combining real-time spatial intelligence and patient-specific digital twins for robot-assisted and minimally invasive soft-tissue surgery
Pre-Seed · $3M · 2026-09
$3M - Intrepid Labs
Autonomous labs combining AI, robotics and chemistry to accelerate drug compound formulation
Seed · $11M · 2025-05
$11M - NexusMD
AI agents that handle physicians' administrative tasks such as medical documentation and referrals
Seed · $4M · 2025-06
$4M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
General Catalyst
40 Life Sciences deals in the last 24 months · 19 at a nearby stage · 36 in North America
Request intro →Y Combinator
38 Life Sciences deals in the last 24 months · 26 at a nearby stage · 31 in North America
Request intro →Andreessen Horowitz
24 Life Sciences deals in the last 24 months · 11 at a nearby stage · 22 in North America
Request intro →Khosla Ventures
21 Life Sciences deals in the last 24 months · 7 at a nearby stage · 20 in North America
Request intro →Thrive Capital
18 Life Sciences deals in the last 24 months · 3 at a nearby stage · 15 in North America
Request intro →Lightspeed
17 Life Sciences deals in the last 24 months · 5 at a nearby stage · 15 in North America
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.